Health Evofem Biosciences to Report Second Quarter 2022 Results and Provide Corporate Update on Thursday, August 4, 2022 August 1, 2022
Health GeoVax Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate Against Sudan Ebolavirus Showing 100% Protection With a Single Immunization August 1, 2022
Health Evoke Pharma Recognizes Gastroparesis Awareness Month through its Support of The International Foundation for Gastrointestinal Disorders (IFFGD) August 1, 2022
Health Evofem Biosciences Discusses Innovative Woman-Controlled Contraceptive with The Stock Day Podcast August 1, 2022
Health BioCardia Announces First Canadian Clinical Site for CardiAMP Cell Therapy Heart Failure Trial August 1, 2022
Health Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering Potentiated Intranasal Oxytocin (TNX-1900) for the Treatment of Pain August 1, 2022
Health Evofem Announces Completion of Last Subject Last Visit (LSLV) in Registrational Phase 3 “EVOGUARD” Trial Evaluating Phexxi® for the Prevention of Chlamydia and Gonorrhea in Women August 1, 2022
Health Cosmos Holdings Announces Agreement to Acquire Cana Laboratories, a Legacy European Pharmaceutical Company Established in 1928; Vertically Integrating its Manufacturing and R&D Capabilities and Expanding its Product Pipeline with New Brands July 25, 2022
Health Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome July 25, 2022